Nancy D Leslie MD
Clinical Biochemical Genetics, Clinical Genetics
Professor, Pediatrics, University of Cincinnati College of Medicine
Join to View Full Profile
3333 Burnet AveMl 4006Cincinnati, OH 45229
Phone+1 513-636-4760
Fax+1 513-636-7297
Dr. Leslie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cincinnati Children's Hospital Medical CenterResidency, Medical Genetics and Genomics, 1993 - 1996- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Endocrinology, 1982 - 1989
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1979 - 1982
Washington University in St. Louis School of MedicineClass of 1979
Certifications & Licensure
OH State Medical License 1983 - 2026
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Pediatrics Pediatrics- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
Publications & Presentations
PubMed
- 3 citationsPathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.Dmitrijs Rots, Sanaa Choufani, Victor Faundes, Alexander J M Dingemans, Shelagh Joss
American Journal of Human Genetics. 2024-08-08 - 4 citationsA Qualitative Study: Mothers' Experiences of Their Child's Late-Onset Pompe Disease Diagnosis Following Newborn Screening.Kaylee Crossen, Lisa Berry, Melanie F Myers, Nancy Leslie, Cecilia Goueli
International Journal of Neonatal Screening. 2022-07-19 - 1 citationsMotor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort.Tina Duong, Priya S Kishnani, Kristina An Haack, Meredith C Foster, James B Gibson
Journal of Neuromuscular Diseases. 2022-01-01
Grant Support
- Rhgaa Treatment In Patients Over 6 And LESS THAN 36 Months OldNational Center For Research Resources2005–2007
- Iduronate-2-Sulfatase Replacement Therapy In MPS IINational Center For Research Resources2004–2007
- Rhgaa Treatment In Patients <6 Months OldNational Center For Research Resources2005–2006
- Rhgaa Treatment In Patients Over 6 &Less THAN 36 MonthsNational Center For Research Resources2004
- Genetic Models For GalactosemiaNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1998
- Genetic Models For GalactosemiaNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Ontogeny Of Glucagon Action: Monoclonal Antibody StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
